Medico Remedies Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	2,064	1,509	1,449	1,404	1,210
Other Revenue	-	-	-	-	0
Revenue	2,064	1,509	1,449	1,404	1,210
Revenue Growth (YoY)	36.73%	4.15%	3.19%	16.04%	-1.12%
Cost of Revenue	1,513	1,102	1,112	1,057	887.41
Gross Profit	550.5	407.01	336.79	347.51	322.8
Selling, General & Admin	73.98	63.63	59.68	57.91	60.09
Other Operating Expenses	306.25	193.35	148.02	193.41	188.98
Operating Expenses	411.17	287.28	236.49	278.52	271.25
Operating Income	139.32	119.73	100.3	68.99	51.55
Interest Expense	-18.06	-8.54	-6.43	-5.8	-5.07
Interest & Investment Income	-	1.05	0.94	1.01	0.7
Currency Exchange Gain (Loss)	-	25.85	20.31	38.46	19.59
Other Non Operating Income (Expenses)	59.34	-3.04	-1.81	-1.67	-1.56
EBT Excluding Unusual Items	180.6	135.04	113.32	100.99	65.22
Gain (Loss) on Sale of Assets	-	-	0.03	-	-0.39
Pretax Income	180.6	135.04	113.35	100.99	64.83
Income Tax Expense	49.44	34.11	30.44	28.57	16.71
Net Income	131.15	100.93	82.91	72.42	48.12
Net Income to Common	131.15	100.93	82.91	72.42	48.12
Net Income Growth	29.94%	21.74%	14.49%	50.49%	85.79%
Shares Outstanding (Basic)	83	83	83	83	83
Shares Outstanding (Diluted)	83	83	83	83	83
Shares Change (YoY)	0.03%	-	-	-	-
EPS (Basic)	1.58	1.22	1.00	0.87	0.58
EPS (Diluted)	1.58	1.22	1.00	0.87	0.58
EPS Growth	29.90%	21.74%	14.84%	50.03%	85.79%
Free Cash Flow	13.85	17.05	-0.4	15.75	-0.51
Free Cash Flow Per Share	0.17	0.20	-0.01	0.19	-0.01
Gross Margin	26.67%	26.96%	23.24%	24.75%	26.67%
Operating Margin	6.75%	7.93%	6.92%	4.91%	4.26%
Profit Margin	6.35%	6.69%	5.72%	5.16%	3.98%
Free Cash Flow Margin	0.67%	1.13%	-0.03%	1.12%	-0.04%
EBITDA	170.27	145.33	124.75	92.05	72.35
EBITDA Margin	8.25%	9.63%	8.61%	6.55%	5.98%
D&A For EBITDA	30.95	25.61	24.45	23.05	20.8
EBIT	139.32	119.73	100.3	68.99	51.55
EBIT Margin	6.75%	7.93%	6.92%	4.91%	4.26%
Effective Tax Rate	27.38%	25.26%	26.86%	28.29%	25.77%
Revenue as Reported	2,123	1,536	1,470	1,444	1,231
Advertising Expenses	-	0.86	0.47	0.37	5.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.